Home » Topics » Regulatory » Patents

Patents
RSS

Heptares Therapeutics discloses muscarinic M1 and M4 receptor agonists

Oct. 5, 2016

Merck & Co. patents PDE2A inhibitors

Oct. 5, 2016

Calitor Sciences and Sunshine Lake Pharma present PI3K inhibitors

Oct. 4, 2016

Korea University Research and Business Foundation develops TSLP ligands

Oct. 4, 2016

Eli Lilly describes BACE1 inhibitors

Oct. 4, 2016

Oncodesign discloses ALK-1 and/or ALK-2 inhibitors

Oct. 4, 2016

Bayer Pharma patents factor XIa inhibitors

Oct. 4, 2016

Genentech and Roche present JAK1 inhibitors

Oct. 3, 2016

Hetero Research Foundation develops antiviral agents

Oct. 3, 2016

Roche describes mGlu4 receptor positive allosteric modulators

Oct. 3, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...